Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2021 Mar 08

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Medica 2021 Mar 08

DOI: 10.23736/S0026-4806.21.07281-5

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Epidemiology of severe asthma and international register

Elena TAGLIABUE , Elisa TRUCCO, Fulvio BRAIDO

Clinic of Respiratory Disease and Allergology, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy


PDF


Severe asthma (SA) in an asthma that requires therapy with high dose inhaled corticosteroids with a second controller, or oral corticosteroids, to ensure that it does not become ‘‘uncontrolled’’, or that it does not respond to appropriate therapy. Severe asthma has a great impact on quality of life. There is a great heterogeneity of this disease, not only from a clinical point of view, but also from a functional and pathophysiological one. It’s really hard to identify specific characteristics that identify this subgroup. Specific registers of SA, both national and international, are really important to describe the epidemiological characteristics of the disease and to analyze the clinical characteristics of the various subgroups of patients. This is an excellent starting point to be able to investigate the characteristics of the disease in detail.


KEY WORDS: Severe asthma; Severe asthma registry; Severe asthma epidemiology

top of page